Some posters seem to have very thick rose tinted glasses, and...

Some posters seem to have very thick rose tinted glasses, and are waiting on a Deus Ex Machina to save the company, and bring about a rise in share price.

If this "acquisition" is the penultimate deal, it will need to increase the shareprice by over 4,100% just to break even with their previous company transforming capital raise.

The market cap would go from 5.44mil to 226.63mil. What sort of revenue would be needed to drive that? $54,000 a quarter certainly wont cut it. a 100 fold increase to 5.4mil a quarter (~22mil annualised) isnt going to justify a 226mil market cap.

The extremely worrying points in recent history are;
1. Loss of HHC with no notification to shareholders.
2. Termination of Medcan deal and subsequent lawsuit, again with as little information released as possible.
3. 50% markdowns extending well past the traditional black friday sales, showing a recognition of their failure to generate any meaningful consumer traction.
4. AGM with no online presence. No presentation or directors address.
5. Extended trading halt for an Acquisition that the company seem unable to finalise. 6 Extensions and counting. .

I'm sure there are more, but these are the biggest red flags for 2022.